Related Experiment Videos
Hyperacute rejection of the transplanted mouse heart
G Hisatake1, E Hammond, M Ives
1Department of Pathology, University of Utah Medical Center, Salt Lake City 84132.
Transplantation
|June 1, 1989
Summary
Hyperacute rejection (HAR) of mouse and rat hearts is influenced by prior sensitization. Most transplanted hearts showed accelerated rejection, not HAR, with varying responses to serum and cell transfers.
Area of Science:
- Transplantation immunology
- Xenotransplantation research
- Immunological rejection mechanisms
Background:
- Heterotopic heart transplantation in mice and rats is a model for studying rejection.
- Hyperacute rejection (HAR) is a rapid form of graft rejection.
- Understanding rejection kinetics is crucial for improving transplant outcomes.
Purpose of the Study:
- To investigate the impact of prior sensitization on the type and kinetics of heart graft rejection in mice and rats.
- To compare rejection patterns between mice and rats following different sensitization protocols.
- To determine the roles of serum and lymphoid cells in mediating rejection.
Main Methods:
- Heterotopic mouse and rat heart transplantation to MHC-disparate recipients.
- Sensitization protocols involving sequential skin grafts or intradermal lymphoid cell injections.
- Assessment of graft survival and rejection type (hyperacute vs. accelerated).
- Adoptive transfer of serum and lymph node cells from sensitized donors.
Main Results:
- Prior sensitization with skin grafts or lymphoid cells influenced rejection outcomes in mouse and rat heart transplants.
- Most hearts underwent accelerated rejection, with a subset experiencing HAR.
- Rat heart transplants showed faster HAR and more severe vascular changes than mouse hearts.
- Serum transfer induced occasional HAR, while cell transfer primarily led to accelerated rejection.
Conclusions:
- The type and intensity of rejection following heart transplantation are significantly modulated by the nature and extent of prior donor-specific sensitization.
- Accelerated rejection is a more common outcome than HAR in these models, even with potent sensitization.
- Different components of the immune system (serum vs. cells) play distinct roles in mediating HAR and accelerated rejection.